Hepatitis B Virus (HBV) Reactivation Following Pharmacological Eradication of Hepatitis C Virus (HCV)

Hepatitis B Virus (HBV) Reactivation Following Pharmacological Eradication of Hepatitis C Virus (HCV)

The US Food and Drug Administration issued a black box warning related to the risk of reactivation of overt/occult hepatitis B virus (HBV) infection during direct acting-antivirals (DAA) treatment. This review evaluated the prevalence of HBV reactivation after hepatitis C virus (HCV) pharmacological...

Full description

Bibliographic Details
Main Authors: Mariantonietta Pisaturo, Margherita Macera, Loredana Alessio, Federica Calò, Nicola Coppola
Format: Article
Language:English
Published: MDPI AG 2019-09-01
Series:Viruses
Subjects:
HBV/HCV dual infection
HBsAg
occult HBV infection
overt HBV reactivation
occult HBV reactivation
Online Access:https://www.mdpi.com/1999-4915/11/9/850

Internet

https://www.mdpi.com/1999-4915/11/9/850

Similar Items